A Clinical Observational Study Evaluating the Efficacy of Cerave Neuroceramide Intensive Repair Body Lotion .

Inclusion Criteria

• •Individuals with moderate to severe skin dryness as assessed by a clinician (ODS score of 2 or 3)
• •Individuals with moderate to severe self-reported skin itching as assessed by a clinician (NRS ≥ 1)
• •Individuals aged 55 years and older
• •Open to patients with one or more of the following conditions:
• •1. History of atopic dermatitis;
• •2. Currently using a stable medication regimen prescribed and monitored by a physician (ongoing use), where the medication has side effects causing skin dryness (e.g., statins, calcium channel blockers, diuretics, antiplatelet agents, ACE inhibitors, beta-blockers, adrenergic receptor agonists, immunosuppressants, etc.);
• •3. Patients with systemic diseases associated with dryness (diagnosed and managed by a physician), such as diabetes, hyperthyroidism, hypothyroidism, or hemodialysis.
• •Voluntarily participate in the trial, understand and agree to sign the informed consent form, and agree to follow the study protocol throughout the study period, including using the study-provided products, not using other similar products, completing a diary, and attending regular follow-up visits as required by the trial.